Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alcoholic liver disease.

A M Diehl1

  • 1Johns Hopkins University, Baltimore, Maryland 21205, USA.

Clinics in Liver Disease
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Alcohol causes liver disease through inflammation and fibrosis, leading to cirrhosis. Effective treatments for alcoholic liver disease (ALD) are lacking, highlighting the need for further research and prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease.

Cell death & disease·2016
Same author

Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.

Gut·2014
Same author

Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.

Gut·2014
Same author

Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy.

Gut·2013
Same author

The hedgehog pathway regulates remodelling responses to biliary obstruction in rats.

Gut·2008
Same author

Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging.

International journal of obesity (2005)·2007
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Area of Science:

  • Hepatology
  • Immunology
  • Toxicology

Background:

  • Alcohol consumption is a major cause of chronic liver disease.
  • Alcoholic liver disease (ALD) pathogenesis involves inflammatory mediators and fibrogenesis.
  • ALD progresses to severe liver injury and cirrhosis.

Purpose of the Study:

  • To summarize the current understanding of alcoholic liver disease pathogenesis.
  • To highlight the challenges in treating ALD.
  • To underscore the public health significance of ALD.

Main Methods:

  • Review of existing literature on ALD.
  • Analysis of the role of cytokines in alcohol-induced liver injury.
  • Examination of factors contributing to ALD prevalence.

Related Experiment Videos

Main Results:

  • Alcohol consumption and metabolism generate inflammatory cytokines.
  • These cytokines drive hepatotoxicity and fibrogenesis, leading to liver damage.
  • ALD remains a prevalent and disabling condition in the US due to limited effective therapies and patient non-adherence.

Conclusions:

  • Understanding ALD pathogenesis is crucial for developing targeted therapies.
  • The lack of effective treatments and challenges in alcohol abstinence contribute to ALD's high prevalence.
  • Further research is needed to combat this widespread liver disease.